US domestic antimicrobial sales drop 33 percent on FDA restrictions
date:Dec 20, 2018
on critical, science-based analysis, public health impact, feedback from stakeholders and resource availability. Down the road, we will continue to engage our stakeholders and the public as we develop and implement strategies for addressing individual actions and goals identified in this plan, said Gottlieb.

Gottlieb noted that this action plan is an integral piece to the agencys 2019 Strategic Approach for Combating AMR in both veterinary and human health care settings, including efforts to fa
6/10 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/16 06:48